Infinity Pharmaceuticals Stock

Infinity Pharmaceuticals Equity

The The Equity of Infinity Pharmaceuticals (INFIQ) as of Aug 4, 2026 is -19.05 M USD. In the previous year, The Equity was 21.57 M USD — a change of -188.32% (lower).

Equity

-19.05 MUSD

YoY

-188.32%

Last updated:

In 2026, Infinity Pharmaceuticals's equity was -19.05 M USD, a -188.32% increase from the 21.57 M USD equity in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Infinity Pharmaceuticals's Equity

Infinity Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Infinity Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Infinity Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Infinity Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Infinity Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Infinity Pharmaceuticals stock

The Equity of Infinity Pharmaceuticals is -19.05 M USD in 2026.

The Equity of Infinity Pharmaceuticals changed from 21.57 M USD to -19.05 M USD, representing a -188.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Infinity Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Infinity Pharmaceuticals

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Infinity Pharmaceuticals